Mice harboring the human <i>SLC30A8</i> R138X loss-of-function mutation have increased insulin secretory capacity
Sandra Kleiner(Boehringer Ingelheim (Germany)), Jesper Gromada(Rapt Therapeutics (United States))
Cited by 63
Related Papers
Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways
|Diabetes|2006|491
ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
|New England Journal of Medicine|2017|329
Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
|Journal of Lipid Research|2020|202
Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition
|Proceedings of the National Academy of Sciences|2017|20